Photofrin is a drug owned by Pinnacle Biologics Inc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Aug 01, 2012. Details of Photofrin's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5438071 | Stable porfimer sodium compositions and methods for their manufacture |
Aug, 2012
(12 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Photofrin is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Photofrin's family patents as well as insights into ongoing legal events on those patents.
Photofrin's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Photofrin's generic launch date based on the expiry of its last outstanding patent is estimated to be Aug 01, 2012 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Photofrin Generics:
There are no approved generic versions for Photofrin as of now.
About Photofrin
Photofrin is a drug owned by Pinnacle Biologics Inc. Photofrin uses Porfimer Sodium as an active ingredient. Photofrin was launched by Pinnacle Biolgs in 1995.
Approval Date:
Photofrin was approved by FDA for market use on 27 December, 1995.
Active Ingredient:
Photofrin uses Porfimer Sodium as the active ingredient. Check out other Drugs and Companies using Porfimer Sodium ingredient
Dosage:
Photofrin is available in injectable form for injection use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 75MG/VIAL | INJECTABLE | Prescription | INJECTION |